Patents by Inventor Jingxue Zhang

Jingxue Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240077548
    Abstract: Disclosed is a device and method for testing a crimping status of a hardware fitting and cable conductors. The device includes a device body, a cable fixing assembly is arranged on an insulation console and configured to fix a crimping status test piece on the insulation console. According to the present disclosure, technical problems are solved: the existing device for testing a crimping status of a hardware fitting and cable conductors lacks of a fixing assembly, if an operator touches a test piece being tested, the connection between the test piece and a current generator or a contact resistance tester is likely to be interrupted, resulting in a large error in a test result.
    Type: Application
    Filed: September 1, 2023
    Publication date: March 7, 2024
    Inventors: Hongbin Yao, Jingxu Zhang, Yuan Tian
  • Patent number: 11040086
    Abstract: An active peptide for enhancing the phagocytic functions of retinal pigment epithelium and a use thereof, which belongs to the technical field of preparing drugs for treating retinal neurodegenerative diseases, are described. The amino acid sequence of the active peptide for enhancing the phagocytic functions of retinal pigment epithelium described in the disclosure was as shown in SEQ ID NO.1. The active peptide of the present invention has biological characteristics similar to those of Gas6 full-length proteins, with an effect of enhancing the phagocytic functions of retinal pigment epithelium.
    Type: Grant
    Filed: December 30, 2019
    Date of Patent: June 22, 2021
    Assignee: Beijing Tongren Hospital, Capital Medical University
    Inventors: Jingxue Zhang, Shen Wu, Ningli Wang
  • Publication number: 20200390853
    Abstract: The disclosure relates to an active peptide for enhancing the phagocytic functions of retinal pigment epithelium and a use thereof, which belongs to the technical field of preparing drugs for treating retinal neurodegenerative diseases. The amino acid sequence of the active peptide for enhancing the phagocytic functions of retinal pigment epithelium described in the disclosure was as shown in SEQ ID NO.1. The active peptide of the present invention has biological characteristics similar to those of Gash full-length proteins, with an effect of enhancing the phagocytic functions of retinal pigment epithelium.
    Type: Application
    Filed: December 30, 2019
    Publication date: December 17, 2020
    Inventors: Jingxue Zhang, Shen Wu, Ningli Wang